lisinopril
- Product NDC
- 0615-7775
- 11-digit product format
- 006157775
- Labeler code
- 0615
- Product ID
- 0615-7775_487b2c2b-c0e3-4857-8e5f-fa030201ca27
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA075994
- Marketing category
- ANDA
- Marketing start
- 2002-07-01
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7775-05 | 2021-07-08 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-30 | 2021-07-08 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-31 | 2021-07-08 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-39 | 2021-07-08 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |
| 0615-7775-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1b31-f424-e053-dadaa90a57ce | 47ecf380-7ad7-411c-a120-8396d8590acc |